H2 Times
A comprehensive online and offline hydrogen platform with world-leading features. News and magazine with a focus on lifestyle and education.
The editorial team provides information about molecular hydrogen in an engaging and novel way. It features interviews with experts, celebrities who are in touch with hydrogen issues. Stories of people who have had their lives changed by molecular hydrogen are also an integral part of it. The first hydrogen newspaper covers topics in the health, beauty, energy, industrial and medical sectors.
6 published
issues
30+ interviews
Printed and online version
200+ published articles concerning hydrogen
What do we write about
H2 Times is H2 Global Group’s exclusive media platform, providing comprehensive coverage of hydrogen technologies in the HealthTech, MedTech, Energy, Industrial and Medical sectors.
As the world’s first hydrogen newspaper, we connect science with practice, popularizing the latest discoveries and reporting on innovations that are shaping the future of hydrogen. Our editorial team travels across the country and around the world to bring you breaking news, expert interviews and stories of people whose lives have been changed by molecular hydrogen
Current news
We report on the latest research, applications and investments in molecular hydrogen.
Exclusive interviews
We bring you insights from experts, scientists, doctors and celebrities who are actively involved in hydrogen technology.
Stories and experiences
We share authentic stories of people who have discovered a new dimension of vitality and regeneration through hydrogen.
Field Reports
We follow the most important hydrogen events, scientific conferences and projects that are shaping the future of the industry.
Education and popularization
We explain complex topics in a clear and engaging way to make molecular hydrogen appeal to the professional and general public.
Available to everyone
H2 Times is available not only online, but also in printed form – for free at our store. Each edition brings exclusive content that expands the view of hydrogen technologies in the context of health, science and modern lifestyle.
Who wrote about us
We are regularly quoted in leading Czech and foreign media that follow the development of hydrogen technologies. We provide up-to-date overviews, analyses and expert commentaries on the most important trends in the field of molecular hydrogen.
H2 TV
H2 Times offers multimedia content that brings the world of hydrogen technology to life not only in articles, but also in video reports and interviews. Our video portal features discussions with leading experts, overviews of the latest innovations and recordings from key conferences.
Latest news
Molecular Hydrogen Not Only Against Alzheimer’s Dementia — The Medicine of the Future
In this episode, Prof. Shigeo Ohta and David Maršálek, founder of H2 Global Group, return to the beginning of their “hydrogen” journey. Ohta describes how his academic research gradually led him to the long-term study of molecular hydrogen and why he sees it as a...
Czechs Have a More Open Path to Investing in the “Medicine of the Future.” Why Capital Is Moving into MedTech, HealthTech, Mental Health, and Longevity
Just a few years ago, investments in healthcare and medical innovation were mainly opportunities for large funds, strategic players, and a narrow group of specialized investors. Today, the situation is changing rapidly. Healthcare is becoming one of the world’s main investment themes — not only because of returns, but also because of social necessity: aging populations, high household and public healthcare spending, shortages in care capacity, and the enormous burden placed on families caring for chronically ill relatives.
Molecular Hydrogen on the Path to Modern Medicine
A Global Problem Without a Simple Solution Dementia and neurodegenerative diseases are among the greatest challenges of modern medicine today. They affect tens of millions of people worldwide, and their impact is not only medical but also social and economic. The...
Contact us
H2 Times s.r.o., IČ: 17394007
Česká 3229/27 700 30 Ostrava